We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Thiolated Chitosan as an Intestinal Absorption Carrier with Hesperidin Encapsulation for Obesity Treatment.
- Authors
Chen, Tzu-Chien; Ho, Yu-Yu; Tang, Rui-Chian; Ke, Yong-Chen; Lin, Jhih-Ni; Yang, I-Hsuan; Lin, Feng-Huei
- Abstract
Obesity is characterized as abnormal or excessive fat accumulation harmful to one's health, linked to hormonal imbalances, cardiovascular illness, and coronary artery disease. Since the disease stems mainly from overconsumption, studies have aimed to control intestinal absorption as a route for treatment. In this study, chitosan-thioglycolic acid (CT) was developed as a physical barrier in the gastrointestinal tracts to inhibit nutrient uptake. CT exhibits a superior mucoadhesive property compared to chitosan both in vitro and in vivo for the ability to form disulfide bonds with the intestinal mucosa. For CT as a potential drug delivery platform, hesperidin, a herb for bodyweight control in traditional Chinese medication, is encapsulated in CT and can be released consistently from this absorption barrier. In animal studies, CT encapsulated with hesperidin (CTH) not only results in a weight-controlling effect but limits adipose accumulation by hindering absorption, suggesting a potential role in obesity treatment. Neither CT nor CTH exhibit cytotoxicity or produce adverse immunological reactions in vivo.
- Subjects
OBESITY; POLYSACCHARIDES; IN vitro studies; DRUG delivery systems; IN vivo studies; ANIMAL experimentation; NUTRITIONAL requirements; COMPARATIVE studies; INTESTINAL absorption; INTESTINAL mucosa; ENZYME inhibitors; FLAVANONES; MICE; CHINESE medicine; PHARMACODYNAMICS
- Publication
Nutrients, 2021, Vol 13, Issue 12, p4405
- ISSN
2072-6643
- Publication type
Article
- DOI
10.3390/nu13124405